Clinical trial
A 5-way Treatment Period Trial of Single Doses of Intranasal GSK256066 in…
NCT00464568 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00464568 |
|---|---|
| Title | A 5-way Treatment Period Trial of Single Doses of Intranasal GSK256066 in Patients With Rhinitis |
| Official title | A Randomised, Open, Placebo-controlled 5-way Crossover Trial of Single Doses of Intranasal GSK256066 in Subjects With Seasonal Allergic Rhinitis (SAR). |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Rhinitis, Allergic, Seasonal |
| Intervention type | Drug |
| Interventions | GSK256066 |
| Enrollment | 32 |
| Start date | Mar 28, 2007 |
| Primary completion | May 16, 2007 |
| Completion | May 16, 2007 |
| First posted | Apr 23, 2007 |
| Last update posted | Aug 20, 2018 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: